International Journal of Infectious Diseases (Jul 2019)
Analysis of dengue specific memory B cells, neutralizing antibodies and binding antibodies in healthy adults from India
- Sivaram Gunisetty,
- Kaustuv Nayak,
- Ramesh Chandra Rai,
- Yadya Chawla,
- Elluri Seetharami Reddy,
- Charu Aggarwal,
- Deepti Maheshwari,
- Harekrushna Panda,
- Nasim Akhtar Ansari,
- Prabhat Singh,
- Manpreet Kaur,
- Kritika Dixit,
- Pragati Sharma,
- Priya Bhatnagar,
- Lalita Priyamvada,
- Siddhartha Kumar Bhaumik,
- Syed Fazil Ahamed,
- Rosario Vivek,
- Pratima Ray,
- Anita Shet,
- Poonam Coshic,
- Rakesh Lodha,
- Sushil Kumar Kabra,
- Dil Afroze,
- Adfar Yousuf,
- Rafi Ahmed,
- Kaja Murali-Krishna,
- Anmol Chandele
Affiliations
- Sivaram Gunisetty
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India; Department of Pediatrics, Division of Infectious Disease, Emory University School of Medicine, Atlanta, GA, USA; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA
- Kaustuv Nayak
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Ramesh Chandra Rai
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Yadya Chawla
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Elluri Seetharami Reddy
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Charu Aggarwal
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Deepti Maheshwari
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Harekrushna Panda
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Nasim Akhtar Ansari
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Prabhat Singh
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Manpreet Kaur
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Kritika Dixit
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Pragati Sharma
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Priya Bhatnagar
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India
- Lalita Priyamvada
- Department of Pediatrics, Division of Infectious Disease, Emory University School of Medicine, Atlanta, GA, USA
- Siddhartha Kumar Bhaumik
- Department of Pediatrics, Division of Infectious Disease, Emory University School of Medicine, Atlanta, GA, USA
- Syed Fazil Ahamed
- Division of Infectious Diseases, St. John’s Research Institute, St. John’s National Academy of Health Sciences, Koramangala, Bangalore, 560034, India; The University of Trans-Disciplinary Health Sciences & Technology, Bangalore, 560064, Karnataka, India
- Rosario Vivek
- Division of Infectious Diseases, St. John’s Research Institute, St. John’s National Academy of Health Sciences, Koramangala, Bangalore, 560034, India
- Pratima Ray
- Department of Biotechnology, School of Clinical and Life Sciences, Jamia Hamdard, Mehrauli-Bardarpur Road, New Delhi, 110062, India
- Anita Shet
- Division of Infectious Diseases, St. John’s Research Institute, St. John’s National Academy of Health Sciences, Koramangala, Bangalore, 560034, India; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, 21231, USA
- Poonam Coshic
- Department of Transfusion Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India
- Rakesh Lodha
- Division of Pediatric Pulmonology and Intensive Care, Department of Pediatrics, AIIMS, New Delhi, India
- Sushil Kumar Kabra
- Division of Pediatric Pulmonology and Intensive Care, Department of Pediatrics, AIIMS, New Delhi, India
- Dil Afroze
- Immunology & Molecular Medicine, Sher-i-Kashmir Institute of Medical Sciences-Srinagar, Jammu and Kashmir, 190011, India
- Adfar Yousuf
- Immunology & Molecular Medicine, Sher-i-Kashmir Institute of Medical Sciences-Srinagar, Jammu and Kashmir, 190011, India
- Rafi Ahmed
- Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, 30322, USA
- Kaja Murali-Krishna
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India; Department of Pediatrics, Division of Infectious Disease, Emory University School of Medicine, Atlanta, GA, USA; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA; Corresponding authors at: ICGEB-Emory Vaccine Center, International center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India; Department of Pediatrics, Division of Infectious Disease, Emory University School of Medicine, Atlanta, GA 30322, USA.
- Anmol Chandele
- ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India; Corresponding authors.
- Journal volume & issue
-
Vol. 84
pp. S57 – S63
Abstract
Background: The Indian population is facing highest dengue burden worldwide supporting an urgent need for vaccines. For vaccine introduction, evaluation and interpretation it is important to gain a critical understanding of immune memory induced by natural exposure. However, immune memory to dengue remains poorly characterized in this region. Methods: We enumerated levels of dengue specific memory B cells (MBC), neutralizing (NT) and binding antibodies in healthy adults (n = 70) from New Delhi. Results: NT-antibodies, binding antibodies and MBC were detectable in 86%, 86.56% and 81.63% of the subjects respectively. Among the neutralizing positive subjects, 58%, 27%, 5% and 10% neutralized all four, any three, any two and any one dengue serotypes respectively. The presence of the neutralizing antibodies was associated with the presence of the MBC and binding antibodies. However, a massive interindividual variation was observed in the levels of the neutralizing antibodies (range, <1:50–1:30,264), binding antibodies (range, 1:3,000–1:134,000,) as well as the MBC (range = 0.006%–5.05%). Conclusion: These results indicate that a vast majority of the adults are immune to multiple dengue serotypes and show massive interindividual variation in neutralizing/binding antibodies and MBCs – emphasizing the importance of monitoring multiple parameters of immune memory in order to properly plan, evaluate and interpret dengue vaccines. Keywords: Dengue, India, Neutralizing antibody, Memory B-cell